Filing Details

Accession Number:
0001192482-21-000094
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-01-22 16:05:24
Reporting Period:
2021-01-19
Accepted Time:
2021-01-22 16:05:24
Original Submission Date:
2021-01-21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267565 Collegium Pharmaceutical Inc COLL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1734919 R. Shirley Kuhlmann C/O Collegium Pharmaceutical, Inc.
100 Technology Center Drive
Stoughton MA 02072
Evp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-19 45,360 $0.00 102,891 No 4 A Direct
Common Stock Acquisiton 2021-01-19 6,772 $0.00 109,663 No 4 A Direct
Common Stock Disposition 2021-01-20 6,081 $24.45 103,582 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
  2. On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 6,772 performance share units granted in two prior years.
  3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020.